Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients

Summary

We study if the administration of intralesional Adalimumab (directly injected in the stricture) associated to endoscopic dilatation has a higher success rate at week 8 compared with placebo in patients with Crohn's disease who had confirmed intestinal stenosis (3 stenosis as maximum)

Timeline

Start

2014-02-14

Primary completion

2018-06-30

Completion

2018-06-30

Drugs

Indications